活性分子抑制剂-Amadis Chemical

图片	名称及描述
	替曲吉珠单抗 Tildrakizumab A10113591326244-10-3 97%	Detail
	2-氨基-4-(3,4-二羟基苯基)-6-(4-氟苯基)烟腈 IL-4-inhibitor-1 A10114091332184-63-0 98%	Detail
	(E)-8-(3-(4-氯苯基)丙烯酰基)-3-(3,4-二氯苄基)-1-氧杂-3,8-二氮杂螺[4.5]癸烷-2-酮 GSK682753A A10114431334294-76-6 98%	Detail
	(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-甲氧基-8-(4-甲氧基苯基)-11-氧代-6a,7-二氢吡咯并[2,1-c][1,4]苯并二氮杂-3-基]氧基]丙氧基]-2-甲氧基-11-氧代-6a,7-二氢吡咯并[2,1-c][1,4]苯并二氮杂-8-基]苯胺基]-1-氧代丙烷-2-基]-2-[3-[2-[2-[2-[3-(2,5-二氧代吡咯-1-基)丙酰氨基]乙氧基]乙氧基]乙氧基]丙酰氨基]-3-甲基丁酰胺 Mal-PEG4-VA-PBD A10115561342820-68-1 98%	Detail
	α2β1 Integrin Ligand Peptide TFA α2β1 Integrin Ligand Peptide TFA A1011578134580-64-6 97%	Detail
	rel-3,5-二氯-N-(((1R,5S,6s)-3-(3,3-二甲基丁基)-3-氮杂双环[3.1.0]己烷-6-基)甲基)苯甲酰胺 ML218 A10115871346233-68-8 98%	Detail
	(8-((2-(二甲基氨基)乙基)氨基)-2,3-二苯基吡啶并[2,3-b]吡嗪-6-基)氨基甲酸乙酯 UNC10217938A A10116281347749-97-6 97%	Detail
	(3aR,6aR)-N-(4-((3-乙炔基苯基)氨基)-7-甲氧基喹唑啉-6-基)-1-甲基六氢吡咯并[3,4-b]吡咯-5(1H)-甲酰胺 Theliatinib A10116791353644-70-8 97%	Detail
	3-(4-苄基哌嗪-1-基)-N-(4-苯基噻唑-2-基)丙酰胺 TJ-M2010-5 A10117141357471-57-8 97%	Detail
	7-(4-乙基哌嗪-1-基)-5-甲基-2-((2-甲基哌啶-1-基)甲基)-[1,2,4]三唑并[1,5-a]嘧啶 UBE2T/FANCL-IN-1 A10117221359415-02-3 97%	Detail
	SM04554 SM04554 A10117351360540-81-3 97%	Detail
	Vipoglanstat Vipoglanstat A10117361360622-01-0 97%	Detail
	(S)-N,N-二甲基-2-(3-(1-(吡啶-2-基)乙基)-1H-茚满-2-基)乙胺马来酸盐 (S)-(+)-Dimethindene maleate A1011746136152-65-3 98%	Detail
	proTAME proTAME A10117541362911-19-0 95%	Detail
	2-((6-氯-7-环丙基噻吩并[3,2-d]嘧啶-4-基)硫代)乙酸 LP-922056 A10117621365060-22-5 98%	Detail
	RP 70676 RP 70676 A1011775136609-26-2 97%	Detail
	XD 14 XD14 A10118001370888-71-3 97%	Detail
	2-(1,3-二甲基-2,6-二氧代-1,2,3,6-四氢-7H-嘌呤-7-基)-N-异丙基-N-(异丙基氨基甲酰基)乙酰胺 THX-B A10118091372206-64-8 97%	Detail
	6-乙基-3-((3-甲氧基-4-(4-(4-甲基哌嗪-1-基)哌啶-1-基)苯基)氨基)-5-((反式-4-甲氧基环己基)氨基)吡嗪-2-甲酰胺 EML4-ALK kinase inhibitor 1 A10118161373409-08-5 98%	Detail
	2-(4-羟基苯基)-1-(1,3,4,9-四氢-2H-吡啶并[3,4-b]吲哚-2-基)乙烷-1-酮 YH-306 A10118231373764-75-0 97%	Detail